• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外科患者纤溶作用的前瞻性双臂研究。

Prospective double-arm study of fibrinolysis in surgical patients.

作者信息

Kosir M A, Schmittinger L, Barno-Winarski L, Duddella P, Pone M, Perales A, Lange P, Brish L K, McGee K, Beleski K, Pawlak J, Mammen E, Sajahan N P, Kozol R A

机构信息

VA Medical Center, Detroit, Michigan 48201, USA.

出版信息

J Surg Res. 1998 Jan;74(1):96-101. doi: 10.1006/jsre.1997.5233.

DOI:10.1006/jsre.1997.5233
PMID:9536981
Abstract

BACKGROUND

During surgery, the balance between thrombosis and fibrinolysis is altered. Methods reported to increase fibrinolysis, such as compression devices, may reduce venous thrombosis. However, there are no prospective studies comparing methods and the effect on fibrinolysis.

MATERIALS AND METHODS

In a prospective study, general surgical patients were randomized to either sequential compression devices (Group 1) or subcutaneous heparin (Group 2), and fibrinolysis factors were measured in order to determine the effect on the fibrinolysis system. Blood samples were drawn at a similar time of the day with the tourniquet off. Specifically, t-PA antigen, plasminogen activator inhibitor-1 (PAI-1), and D-dimer were measured preoperatively (preop) and on Postoperative Days (POD) 1 and 7 by the ELISA method. Fibrinolysis factors were reported as the mean +/- SD and as percentage change from preoperative values. Noninvasive vascular studies were performed preop, and on POD 1, 7, and 30, by an examination of the infrainguinal venous system and external iliac veins in bilateral lower extremities. Nonambulatory patients were excluded from the study and DVT prophylaxis methods were initiated at surgery and used through POD 2.

RESULTS

For the 136 patients in the study, there were no differences in clinical characteristics such as age, surgical time (all > 60 min), anesthesia type (general or spinal), type of surgical procedure, or other risk factors for DVT. Two DVTs occurred at POD 1 and 30 (both Group 2), and one pulmonary embolism in each group (POD 7 for Group 1; POD 1 for Group 2). For subjects without thrombosis, D-dimer changes were parallel for both groups, increasing through POD 7. Similarly, t-PA antigen levels rose from baseline on POD 1 in both groups, with a return toward baseline by POD 7. The PAI-1 levels increased on POD 1 in both groups, but severalfold more in Group 1 (compression devices). The elevation in PAI-1 decreased by 50% in Group 1 by POD 7, while values returned to normal in Group 2. These changes were not significant using the Mann-Whitney test. Only three patients had thrombotic episodes so that data on changes in fibrinolysis factors are difficult to compare with the larger group.

CONCLUSIONS

This is the first report of a prospective, randomized comparison of fibrinolysis factors using sequential compression devices in comparison to low dose unfractionated heparin in general surgical patients, and comparing postoperative values to preop. Both groups showed an enhanced fibrinolysis by elevation in t-PA antigen and D-dimer on POD 1, as expected when fibrinolysis occurs. While PAI-1 and t-PA work in parallel, the marked elevation of PAI-1 on POD 1 (although only slightly above reference values) and continuing into POD 7 for subjects using compression devices requires further inquiry. The elevation of PAI-1 in the face of elevated t-PA and D-dimer has been reported, but the comparison between patients using sequential compression devices and mini-dose heparin has not been reported. The reason for the elevation requires additional study into other influences on the synthesis, secretion, and/or function of PAI-1 that do not affect t-PA.

摘要

背景

手术过程中,血栓形成与纤溶之间的平衡会发生改变。据报道,一些可增强纤溶的方法,如压迫装置,可能会减少静脉血栓形成。然而,尚无前瞻性研究比较不同方法及其对纤溶的影响。

材料与方法

在一项前瞻性研究中,将普通外科患者随机分为两组,一组使用序贯压迫装置(第1组),另一组皮下注射肝素(第2组),并检测纤溶因子以确定对纤溶系统的影响。在一天中相同时间且松开止血带的情况下采集血样。具体而言,采用酶联免疫吸附测定法在术前(preop)、术后第1天(POD 1)和第7天(POD 7)检测组织型纤溶酶原激活物(t-PA)抗原、纤溶酶原激活物抑制剂-1(PAI-1)和D-二聚体。纤溶因子以平均值±标准差以及相对于术前值的百分比变化形式报告。术前以及POD 1、7和30时,通过检查双侧下肢腹股沟下静脉系统和髂外静脉进行非侵入性血管研究。不活动的患者被排除在研究之外,在手术时开始采用深静脉血栓形成(DVT)预防措施,并持续至POD 2。

结果

本研究中的136例患者在年龄、手术时间(均>60分钟)、麻醉类型(全身麻醉或脊髓麻醉)、手术方式或其他DVT危险因素等临床特征方面无差异。在POD 1和30时发生了2例DVT(均在第2组),每组各有1例肺栓塞(第1组为POD 7;第2组为POD 1)。对于无血栓形成的受试者,两组的D-二聚体变化趋势平行,至POD 7时均升高。同样,两组的t-PA抗原水平在POD 1时均从基线上升,至POD 7时恢复至基线水平。两组的PAI-1水平在POD 1时均升高,但第1组(压迫装置组)升高幅度达数倍。第1组至POD 7时PAI-1升高幅度下降了50%,而第2组的值恢复正常。使用曼-惠特尼检验时,这些变化无统计学意义。仅有3例患者发生血栓事件,因此纤溶因子变化的数据难以与更大的组进行比较。

结论

这是首篇关于普通外科患者中使用序贯压迫装置与低剂量普通肝素进行纤溶因子前瞻性、随机对照比较,并将术后值与术前值进行比较的报告。两组在POD 1时均出现t-PA抗原和D-二聚体升高,提示纤溶增强,这与预期一致。虽然PAI-1和t-PA协同作用,但使用压迫装置的受试者在POD 1时PAI-1显著升高(尽管仅略高于参考值)且持续至POD 7,这一现象需要进一步研究。虽然已有报道在t-PA和D-二聚体升高的情况下PAI-1也升高,但使用序贯压迫装置的患者与小剂量肝素使用者之间的比较尚未见报道。PAI-1升高的原因需要对不影响t-PA的PAI-1合成、分泌和/或功能的其他影响因素进行更多研究。

相似文献

1
Prospective double-arm study of fibrinolysis in surgical patients.外科患者纤溶作用的前瞻性双臂研究。
J Surg Res. 1998 Jan;74(1):96-101. doi: 10.1006/jsre.1997.5233.
2
Fibrinolytic activity in peripheral atherosclerosis in the elderly.老年人外周动脉粥样硬化中的纤溶活性。
Thromb Haemost. 1999 Feb;81(2):275-80.
3
Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.青少年血液纤溶成分的年龄依赖性以及低剂量口服避孕药对青少年凝血和纤溶的影响。
Thromb Haemost. 1988 Dec 22;60(3):361-4.
4
[Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].[急性肺血栓栓塞症患者治疗后血液凝血和纤溶系统及肺血管内皮功能的变化]
Zhonghua Yi Xue Za Zhi. 2007 Nov 20;87(43):3074-8.
5
Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.小儿心脏手术期间止血的变化:生物相容性肝素涂层灌注系统的影响
Ann Thorac Surg. 2004 Mar;77(3):962-7. doi: 10.1016/j.athoracsur.2003.09.028.
6
Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.某些骨髓增殖性综合征中的纤溶酶原激活剂(组织型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂)及纤溶酶原激活剂抑制剂(PAI - 1和PAI - 2)
Med Sci Monit. 2000 Jul-Aug;6(4):684-91.
7
Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.有特发性深静脉血栓形成和/或肺栓塞病史患者的纤溶功能减退。
Thromb Haemost. 1992 Apr 2;67(4):397-401.
8
[Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].[1型和2型糖尿病患者血液中组织型纤溶酶原激活物(T-PA)、其抑制剂(PAI-1)和纤维蛋白原的水平]
Cas Lek Cesk. 1996 Mar 20;135(6):174-7.
9
[Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].[长期血液透析患者静脉闭塞后的纤维蛋白溶解功能减退]
Cas Lek Cesk. 1994 May 30;133(11):346-9.
10
[Effects of thrombolysis and anticoagulation on the functions of vascular endothelial cells and coagulation and fibrinolysis in patients with pulmonary thromboembolism].[溶栓及抗凝治疗对肺血栓栓塞症患者血管内皮细胞功能及凝血与纤溶的影响]
Zhonghua Jie He He Hu Xi Za Zhi. 2005 Sep;28(9):596-9.

引用本文的文献

1
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.美国血液学会 2019 年静脉血栓栓塞症管理指南:手术住院患者静脉血栓栓塞症的预防。
Blood Adv. 2019 Dec 10;3(23):3898-3944. doi: 10.1182/bloodadvances.2019000975.
2
Pediatric Hospital Acquired Venous Thromboembolism.儿科医院获得性静脉血栓栓塞症
Front Pediatr. 2017 Sep 19;5:198. doi: 10.3389/fped.2017.00198. eCollection 2017.
3
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.
心房颤动患者围手术期的桥接抗凝治疗
N Engl J Med. 2015 Aug 27;373(9):823-33. doi: 10.1056/NEJMoa1501035. Epub 2015 Jun 22.
4
Diet as prophylaxis and treatment for venous thromboembolism?饮食可作为静脉血栓栓塞症的预防和治疗手段?
Theor Biol Med Model. 2010 Aug 11;7:31. doi: 10.1186/1742-4682-7-31.
5
Mechanical compression versus subcutaneous heparin therapy in postoperative and posttrauma patients: a systematic review and meta-analysis.机械压迫与术后和创伤后皮下肝素治疗比较:系统评价和荟萃分析。
World J Surg. 2010 Jan;34(1):10-9. doi: 10.1007/s00268-009-0284-z.
6
Inflammation and the host response to injury a large-scale collaborative project: patient-oriented research core standard operating procedure for clinical care X. Guidelines for venous thromboembolism prophylaxis in the trauma patient.炎症与宿主对损伤的反应:一项大型合作项目:以患者为导向的临床护理研究核心标准操作程序X. 创伤患者静脉血栓栓塞预防指南
J Trauma. 2008 Oct;65(4):944-50. doi: 10.1097/TA.0b013e3181826df7.
7
Evidence-based compression: prevention of stasis and deep vein thrombosis.循证加压:预防瘀血和深静脉血栓形成。
Ann Surg. 2004 Feb;239(2):162-71. doi: 10.1097/01.sla.0000109149.77194.6c.
8
Heparins and mechanical methods for thromboprophylaxis in colorectal surgery.肝素及机械方法在结直肠手术中预防血栓形成的应用
Cochrane Database Syst Rev. 2001;2004(3):CD001217. doi: 10.1002/14651858.CD001217.